TTR and cardiac amyloidosis: Although once thought of as untreatable and associated with very poor outcomes, both of the main forms of cardiac amyloidosis (amyloidogenic light chain and transthyretin) are now treatable with chemotherapy and tafamidis (a transthyretin [TTR] stabilizer), respectively1,3.